NDC11 57237006501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 57237-0065-01 | 57237-0065 |
| 57237-0065-1 | 57237-0065 |
| 57237-065-01 | 57237-065 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Flecainide Acetate | FLECAINIDE ACETATE | Rising Pharma Holdings, Inc. | e56335c1-5508-4136-bd2e-18385623e497 | 2024-01-09 | Boxed warning, Adverse reactions | 57237-065-01 57237-065 57237006501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.